|
Wednesday
|
9th April
|
Thursday
|
10th
April
|
Friday
|
11th
April
|
|
9.00-12.00
|
REGISTRATION
|
07.30-8.30
|
REGISTRATION |
|
ADVANCED
AND DISSEMINATED DISEASE Chair : N. Pavlidis-S.Beslia |
|
13.00-18.30
|
SATELITE
SIMPOSIA
|
08.30
|
Principles
of Evidence-based oncology
B.Djulbegović |
9.00
|
The
role of the endocrine therapy in breast cancer E.Vrdoljak |
|
19.00
|
OPENING
AND WELCOME
N.Obralić |
|
EPIDEMILOGY
AND PREVENTION Chair: B.Djulbegović
|
9.20
|
The
role of the chemotherapy in metastatic disease E.Vrbanec |
|
19.30
|
COCTAIL |
9.00
|
Epidemiology
incidence and mortality trends M. Primic - Zakelj
|
9.40
|
Biphosphonates
in the treatment of bone metastases
H. Basic |
| |
|
9.20
|
High risk
women - what can we offer? W. Gatzmeler
|
10.00 |
Palliative
and supportive care T.Cufer |
| |
|
9.40
|
Does screening
save lives - who should be screened and when? B. Djulbegović
|
10.20 |
DISCUSSION |
|
|
|
10.00
|
DISCUSSION |
10.30 |
Coffee
break |
|
|
10.15
|
Coffee
break |
|
PATIENTS
RIGHTS Chair: K.Redmond |
|
|
|
|
DIAGNOSTICS
- Chair:
M. Musanović - F. Dalagija
|
10.50 |
Life
with cancer - Women against breast cancer J.Dizdarevic |
|
|
|
10.30
|
Digital
mammography techniques and
diagnostic accuracy S Ciatto
|
11.10
|
Advocating
for patient`s rights K.Redmond |
|
|
|
10.50
|
Ultrasaund
vs mammography - M. Klančević
|
11.30
|
Quality
of breast cancer guidelines
B. Djulbegović |
| |
|
11.10
|
The
pathologist role for the final desicion;
V. Malamou Mitsi
|
12.00
|
DISCUSSION |
| |
|
11.30 |
Prognostic
and predicive tissue and molecular markers E. Iljazovic |
12.15
|
Lunch |
|
|
11.50
|
DISCUSSION |
|
PANEL
DISCUSSION:
Moderator: B.Djulbegović |
|
|
|
CARCINOMA
IN SITU Moderator:
N. Borojević
|
13.30 |
Surgery: A. Costa |
|
|
12.00
|
General
strategy - Multidisciplinary approach J. Zgajnar
|
13.50
|
Adjuvant
systemic therapy: N. Pavlidis |
|
|
12.20
|
Pathological
classification and prediction of local recurrence V. Malamou -Mitsi
|
14.10 |
Radiotherapy:
L. Athan |
| |
|
12.40
|
Surgical
approaches G. Asimakopoulos Petit
|
14.30 |
Matastatic
disease:
E.Vrdoljak |
| |
|
13.00
|
Radiotherapy
N. Borojevic
|
14.50 |
Paliative
care T. Cufer
|
| |
|
13.20
|
Lunch |
15.10 |
DISCUSSION |
| |
|
|
INVASIVE
BREAST CANCER Chair: O. Duric
|
15.30 |
Closing
remarks |
| |
|
14.20
|
Breast
conserving surgery
A. Costa
|
|
|
| |
|
14.40
|
Sentinel
node biopsy - From the clinical trials to practice J. Zgajnar |
|
|
| |
|
15.00
|
Reconstructive
surgery
R. Dzodic
|
|
|
| |
|
15.20
|
DISCUSSION |
|
|
| |
|
|
Radiotherapy
Chair : R. Orecchia - H. Basic |
|
|
| |
|
15.30
|
Adjuvant
radiootherapy in breast cancer L. Athan
|
|
|
| |
|
16.10
|
Imaging
for breast cancer radiotherapy planning H. Basic |
|
|
| |
|
16.10
|
Intraoperative
radiotherapy R. Orecchia
|
|
|
| |
|
16.30
|
DISCUSSION |
|
|
| |
|
16.50
|
Coffee
break |
|
|
| |
|
|
ADJUVANT
AND NEOADJUVANT SYSTEMIC THERAPY Chair : B.Djulbegović - G.Kecman |
|
|
| |
|
17.10
|
Ovarian
function suppression as part of a tailored adjuvant treatment R.Jaskesz
|
|
|
| |
|
17.30
|
Adjuvant
therapy overview S.Beslia |
|
|
| |
|
17.50
|
Primary
systemic therapy in operable disease N.Pavlidis |
|
|
| |
|
18.10
|
DISCUSSION |
|
|
